Obstetric Anesthesia Subcommittee Minutes
October 20, 2020
1:00-2:00pm EST
Zoom
X
Sharon Abramovitz, Weill Cornell
Arvind Palanisamy, Washington University
Ami Attali, Henry Ford- Detroit
Carlo Pancaro, Michigan Medicine
X
Dan Biggs, University of Oklahoma
Mohamed Tiouririne, University of Virginia
David Swastek, St. Joseph Mercy Ann Arbor
X
Brandon Togioka, Oregon Health Science University
Eric Davies, St. Joseph Mercy Oakland
X
Joshua Younger, Henry Ford, Detroit
X
Ghislaine Echevarria, NYU Langone
Marie-Louise Meng, Duke
X
Ronald George, University of California- San
Francisco
X
Christine Warrick, University of Utah
Jenifer Henderson, St. Joseph Oakland
Ashraf Habib, Duke
X
Rachel Kacmar, University of Colorado
X
Tom Klumpner, Michigan Medicine
Joanna Kountanis, Michigan Medicine
X
Nirav Shah, ASPIRE Director
X
Carlos Delgado Upegui, University of
Washington
X
Kate Buehler, MPOG Clinical Program Manager
Stephanie Lim, University of California- San
Francisco
X
Meridith Bailey, MPOG QI Coordinator
X
Wandana Joshi, Dartmouth University
X
Brooke Szymanski, MPOG QI Coordinator
X
Angel Martino, Sparrow Health System
X
Antonio Gonzalez, Yale
1. Announcements
a. Please update Zoom name with your name so others can get to know you
b. 2021 Meeting Dates
i. February 3, 2021 1-2pm EST
ii. May 5,
20201 1-2pm EST
iii. August 4, 2021 1-2pm EST
iv. November 3, 2021 1-2pm EST
c. Basecamp Forum: please email coordinating center if you are no on the OB Basecamp
Forum
2. OB Specialty Dashboard (see slides for screenshots)
a. Available via ‘Dashboard Beta’ link on mpog.org
b. Replaces existing QI Dashboard and allows us the opportunity to build subspecialty
dashboards to support the subcommittee efforts; supported fully by MPOG- no longer
supported by an outside vendor
c. Obstetric subspecialty dashboard: Auto-filtered to obstetric cases and includes OB-
specific measures
d. Additional filters available for location, age, gender, race/ethnicity, time period
e. Data reflects performance for only the OB population on the subspecialty OB dashboard
3. July 2020 Meeting Recap and Follow-up
a. AKI 01: Postoperative AKI
i. Interest in tracking patients with severe pre-eclampsia
ii. Added a new column on the measure case report tool and a new row to the
web case viewer to identify patients with severe pre-eclampsia
iii. Let us know if there are any issues with false flagging cases with pre-eclampsia
or any cases that may have been missed with the diagnosis code
b. BP 04 Hypotension during Cesarean Delivery measure discussed
i. Include pre-eclampsia and HELLP syndrome patients in the measure
ii. Flag cases with SBP<90mmHg for >5 minutes for all patients (pre-eclampsia,
HELLP included)
iii. Include scheduled and conversion cases
iv. Include urgent and emergent cesarean deliveries
v. Use oxytocin administration start time (bolus or infusion) if neonate delivery
time is not available
4. BP 04: Prolonged Hypotension Measure Update
a. Still in development
i. Complex phenotype development that will support future OB measure
development:
1. OB Anesthesia Start
2. Neuraxial start Time
3. Cesarean Delivery start time
ii. Please provide any feedback regarding the measure not performing as expected
once it is released. This feedback is used to refine the phenotypes further for
improved accuracy.
b. See slides for preliminary performance scores by site (anonymized)
c. BP 04 Exclusions:
i. Cesarean delivery patients undergoing general anesthesia- determined using
Anesthesia Technique- neuraxial phenotype
ii. Patients undergoing cesarean section with hysterectomy (CPT: 01969)
iii. Emergency cesarean delivery with diagnosis of placental abruption (ICD-10:
O45*)
iv. Rupture of uterus (spontaneous) before onset of labor (ICD-10: O71.0)
v. Newborn affected by intrauterine blood loss from ruptured cord (ICD-10: P50.1)
vi. Abnormal uterine or vaginal bleeding, unspecified (ICD-10: N93.9)
1. Should we keep this exclusion? Measure examines codes with a date 30
days before day of surgery to 7 days after
vii. Placenta previa with hemorrhage, third trimester (ICD-10: O44.13)
viii. Hemorrhage from placenta previa, antepartum condition or complication (ICD-
10: 641.13)
ix. Hemorrhage from placenta previa, delivered, with or without mention of
antepartum condition (ICD-10: 641.11)
d. BP 04 Exclusion Discussion:
i. Josh Younger (Henry Ford-Detroit): Is placenta percreta or placenta accreta
included in the exclusion criteria? Those should be excluded.
ii. Christine Warrick (University of Utah): Typically, hypotension occurs after
delivery with those conditions. I would feel comfortable including them as we
can control blood pressure during the case itself.
iii. Tom Klumpner (Michigan Medicine): Would agree- those are usually an issue
after delivery.
iv. Nirav Shah (ASPIRE Director): Not currently excluded but we can examine those
CPT codes and exclude those later if the subcommittee determines that to be
appropriate.
v. Angel Martino Horral (Sparrow): Is there a code for rupture of uterus after the
onset of labor, or only before onset of labor as listed?
vi. Nirav Shah (ASPIRE Director): We will need to look through the code and see if
there is a more applicable code
e. Will post to forum if more questions arise during the measure validation process
f. Plan is to release in the next month- will post to forum when available for review
g. Discussion:
i. Brandon Togioka (OHSU): Would be nice to see breakdown by number of
minutes of hypotension as well as the time from neuraxial placement to delivery
1. Kate Buehler (MPOG): Case list does show number of minutes of
hypotension currently so reviewers will be able to filter on that column
to review cases with longer time periods of hypotension compared to
shorter periods
ii. Sharon Abramovitz (Weill Cornell): Has anyone else had to change their practice
due to Joint Commission policies to not hang phenylephrine before the case in
preparation for emergencies?
iii. Brandon Togioka (OHSU): Also had issues with that in the past- moved to pre-
filled syringes of phenylephrine
iv. Rachel Kacmar (University of Colorado): Same at Colorado, we’ve move to using
pre-made syringes of 10mL of phenylephrine which is enough to treat initial
hypotension before getting a drip started
v. Nirav Shah (ASPIRE Director): Once this measure is released, the dashboard
scores will allow us to review historical data (at least 12 months) to identify
practice changes due to Joint Commission recommendation to not hang
phenylephrine in advance of the case
5. GA 01 General Anesthesia for Cesarean Delivery Measure
a. High interest in this measure topic with the call for measures survey that was sent out in
December 2019
b. Should this be the next measure the OB Subcommittee creates?
c. Around 7% of cesarean deliveries in MPOG have general anesthesia
i. According to SOAP, <5% of cesarean deliveries in US use general anesthesia
ii. Hand review of cases have around 18% with a discernable reason for GA in a
free text note- would need to standardize documentation in order to capture
reason for GA consistently in MPOG
iii. Most sites in MPOG show 0-10 GA cases for cesarean delivery per month over
the last year- individual case review of the few cases/month could help identify
trends for reason for conversion to GA
iv. See slides for preliminary data for GA conversion rates across MPOG sites
(anonymized)
d. Discussion:
i. Josh Younger (Henry Ford-Detroit): Not a good clinical explanation but one
reason for GA conversion may simply be that there isn’t enough time to get
neuraxial placed
ii. Angel Martino-Horrall (Sparrow): Are we aiming to look at the variation across
sites and compare scores of general anesthesia rates or are we focusing on the
reason for conversion?
1. Nirav Shah (ASPIRE Director): I think sites are interested in identifying
the reason for GA at their institution and seeing if there are any
interventions to reduce conversion rate
iii. Ron George (UCSF): We have been working on this for a while at UCSF as our
rate is approximately 12%. We created three different buckets for reasons for
conversion to GA so we can track this better. The reasons we developed for
documenting these conversion reasons in Epic are:
1. Patient comorbidities
2. Failure of regional technique
3. Failure to use regional technique due to timing
iv. Wandana Joshi (Dartmouth): We are interested in this measure too. Are other
sites looking at DPE rates?
v. Angel Martino-Horrall (Sparrow): We trialed the DPE technique at our
institution for a while and it did not make a difference in failure rate or quality
of the block. We are not a training institution though, so the majority of our
providers are experienced providers
vi. Ron George (UCSF): We use a fair amount of CSE (60%) and DPE (40%) and they
all fail
vii. Christine Warrick (University of Utah): A recent abstract presented at ASA by the
University of Chicago showed a 15% decrease in c-section conversion rate to GA
in morbidly obese patients when using DPE compared to CSE.
viii. Nirav Shah (MPOG Director): We have a need for standardization of
documentation around reasons for conversion to GA. If others can share
screenshots of their build, we can work with Epic to share the code and try to
standardize the documentation
ix. Joshua Younger (Henry Ford Detroit): Some of the issues may be coming from
not enough frequent rounding on the floor to assess the epidural. If you have a
method of documenting that you checked in with the patient and checked the
level, you may be able to better find epidurals that stopped working a few hours
prior. I would like to see some sort of measure to see how often we are
checking in on the labor floor
x. Ron George (UCSF): Trying to implement assessment of epidural within the first
hour of placement to determine efficacy of block; looking to document: pain
with contraction, Dermatome block right/left, an original bromage scale right
and left
xi. Antonio Gonzalez (Yale): When we look at failed epidural catheters for c-
sections, looking at how many boluses the patient got and how comfortable the
patient was after block was placed. If the patient got more than 3 or 4 boluses,
we assess the record to see if we missed something with the patient care. The
epidural likely should have been replaced. For GA, another benchmark should
be looking at elective c-sections (which should have a much lower rate)
compared to general anesthesia for urgent or emergent cases.
xii. Carlos Delgado (University of Washington): At UW, we have stipulated q2h
rounding for epidurals – gets tough if you have a busy floor, but it’s doable; and
catheter replacement if >2 boluses
e. Will post to the ASPIRE forum as we continue to develop this measure. Some questions
we have currently:
i. Exclude cesarean deliveries with hysterectomy?
ii. Exclude cesarean deliveries with other procedures list
iii. Which providers should be notified/listed in associated with the case?
6. Plans for 2021
a. General subcommittee feedback
b. Call for measures survey 2021
Meeting adjourned at 1400